Literature DB >> 20096671

The behavioral and biochemical effects of BDNF containing polymers implanted in the hippocampus of rats.

Rachael W Sirianni1, Peter Olausson, Amy S Chiu, Jane R Taylor, W Mark Saltzman.   

Abstract

Brain-derived neurotrophic factor (BDNF) is closely linked with neuronal survival and plasticity in psychiatric disorders. In this work, we engineered degradable, injectable alginate microspheres and non-degradable, implantable poly(ethylene vinyl acetate) matrices to continuously deliver BDNF to the dorsal hippocampus of rats for two days or more than a week, respectively. The antidepressant-like behavioral effects of BDNF delivery were examined in the Porsolt forced swim test. Rats were sacrificed 10days after surgery and tissue samples were analyzed by western blot. A small dose of BDNF delivered in a single infusion, or from a two-day sustained-release alginate implant, produced an antidepressant-like behavior, whereas the same dose delivered over a longer period of time to a larger tissue region did not produce antidepressant-like effects. Prolonged delivery of BDNF resulted in a dysregulation of plasticity-related functions: increased dose and duration of BDNF delivery produced increased levels of TrkB, ERK, CREB, and phosphorylated ERK, while also producing decreased phosphorylated CREB. It is evident from this work that both duration and magnitude of BDNF dosing are of critical importance in achieving functional outcome. 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20096671      PMCID: PMC2834850          DOI: 10.1016/j.brainres.2010.01.041

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  61 in total

1.  Neuronal plasticity and survival in mood disorders.

Authors:  R S Duman; J Malberg; S Nakagawa; C D'Sa
Journal:  Biol Psychiatry       Date:  2000-10-15       Impact factor: 13.382

Review 2.  A neurotrophic model for stress-related mood disorders.

Authors:  Ronald S Duman; Lisa M Monteggia
Journal:  Biol Psychiatry       Date:  2006-04-21       Impact factor: 13.382

3.  Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects.

Authors:  Brian A Hoshaw; Jessica E Malberg; Irwin Lucki
Journal:  Brain Res       Date:  2005-03-10       Impact factor: 3.252

Review 4.  Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression.

Authors:  Husseini K Manji; Jorge A Quiroz; Jonathan Sporn; Jennifer L Payne; Kirk Denicoff; Neil A Gray; Carlos A Zarate; Dennis S Charney
Journal:  Biol Psychiatry       Date:  2003-04-15       Impact factor: 13.382

5.  Intracranial delivery of recombinant nerve growth factor: release kinetics and protein distribution for three delivery systems.

Authors:  W M Saltzman; M W Mak; M J Mahoney; E T Duenas; J L Cleland
Journal:  Pharm Res       Date:  1999-02       Impact factor: 4.200

6.  Tissue Engineering Applied to the Retinal Prosthesis: Neurotrophin-Eluting Polymeric Hydrogel Coatings.

Authors:  Jessica O Winter; Mrudula Gokhale; Ralph J Jensen; Stuart F Cogan; Joseph F Rizzo
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2008-04-01       Impact factor: 7.328

Review 7.  Depression: a case of neuronal life and death?

Authors:  Ronald S Duman
Journal:  Biol Psychiatry       Date:  2004-08-01       Impact factor: 13.382

8.  Transport and elimination of recombinant human NGF during long-term delivery to the brain.

Authors:  C E Krewson; W M Saltzman
Journal:  Brain Res       Date:  1996-07-15       Impact factor: 3.252

9.  Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus.

Authors:  M A Smith; S Makino; R Kvetnansky; R M Post
Journal:  J Neurosci       Date:  1995-03       Impact factor: 6.167

10.  Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain.

Authors:  L A Mamounas; M E Blue; J A Siuciak; C A Altar
Journal:  J Neurosci       Date:  1995-12       Impact factor: 6.167

View more
  14 in total

Review 1.  New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.

Authors:  Michael Maes; Zdenĕk Fišar; Miguel Medina; Giovanni Scapagnini; Gabriel Nowak; Michael Berk
Journal:  Inflammopharmacology       Date:  2012-01-24       Impact factor: 4.473

Review 2.  Approaches for neural tissue regeneration.

Authors:  Loïc Binan; Abdellah Ajji; Gregory De Crescenzo; Mario Jolicoeur
Journal:  Stem Cell Rev Rep       Date:  2014-02       Impact factor: 5.739

Review 3.  The ERK Pathway: Molecular Mechanisms and Treatment of Depression.

Authors:  John Q Wang; Limin Mao
Journal:  Mol Neurobiol       Date:  2019-02-09       Impact factor: 5.590

Review 4.  Depression: a repair response to stress-induced neuronal microdamage that can grade into a chronic neuroinflammatory condition?

Authors:  Karen Wager-Smith; Athina Markou
Journal:  Neurosci Biobehav Rev       Date:  2010-09-29       Impact factor: 8.989

5.  Comparison of the Adulthood Chronic Stress Effect on Hippocampal BDNF Signaling in Male and Female Rats.

Authors:  Somayeh Niknazar; Arezo Nahavandi; Ali Asghar Peyvandi; Hassan Peyvandi; Amin Shams Akhtari; Mohsen Karimi
Journal:  Mol Neurobiol       Date:  2015-07-21       Impact factor: 5.590

Review 6.  Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies.

Authors:  Samir Mitragotri; Paul A Burke; Robert Langer
Journal:  Nat Rev Drug Discov       Date:  2014-08-08       Impact factor: 84.694

7.  Surface-modified nanoparticles enhance transurothelial penetration and delivery of survivin siRNA in treating bladder cancer.

Authors:  Darryl T Martin; Jill M Steinbach; Jingchun Liu; Shogo Shimizu; Hristos Z Kaimakliotis; Marcia A Wheeler; Adam B Hittelman; W Mark Saltzman; Robert M Weiss
Journal:  Mol Cancer Ther       Date:  2013-11-12       Impact factor: 6.261

8.  Nano-particle delivery of brain derived neurotrophic factor after focal cerebral ischemia reduces tissue injury and enhances behavioral recovery.

Authors:  Nia M Harris; Rodney Ritzel; Nickolas S Mancini; Yuhang Jiang; Xiang Yi; Devika S Manickam; William A Banks; Alexander V Kabanov; Louise D McCullough; Rajkumar Verma
Journal:  Pharmacol Biochem Behav       Date:  2016-09-13       Impact factor: 3.533

9.  From molecular to nanotechnology strategies for delivery of neurotrophins: emphasis on brain-derived neurotrophic factor (BDNF).

Authors:  Claire Géral; Angelina Angelova; Sylviane Lesieur
Journal:  Pharmaceutics       Date:  2013-02-08       Impact factor: 6.321

10.  Intranasal Delivery of Recombinant AAV Containing BDNF Fused with HA2TAT: a Potential Promising Therapy Strategy for Major Depressive Disorder.

Authors:  Xian-cang Ma; Peng Liu; Xiao-ling Zhang; Wen-hui Jiang; Min Jia; Cai-xia Wang; Ying-ying Dong; Yong-hui Dang; Cheng-ge Gao
Journal:  Sci Rep       Date:  2016-03-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.